This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients
Breast Cancer Research Open Access 19 March 2012
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bromberg J, Wang TC . (2009). Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15: 17–80.
Chen L, Mory Y, Zilberstein A, Revel M . (1988). Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2 . Proc Natl Acad Sci USA 85: 8037–8041.
Chen L, Shulman LM, Revel M . (1991). IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J Biol Regul Homeostat Agents 5: 125–136.
Chiu JJ, Sgagias MK, Cowan KH . (1996). Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2: 215–221.
Choppin PW . (2007). A Biographical Memoir of Igor Tamm (1922-1995). National Academy of Sciences USA: Washington, DC, pp 1–17.
Krueger J, Ray A, Tamm I, Sehgal PB . (1991). Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 45: 327–334.
Margulies L, Sehgal PB . (1993). Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPβ (NF-IL6) activity by p53 species. J Biol Chem 268: 15096–15100.
Sehgal PB . (1990). Interleukin 6 in infection and cancer. Proc Soc Exp Biol Med 195: 183–191.
Sehgal PB . (1998). Cytokines in the host-tumor interaction. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89–106.
Sehgal PB, Tamm I . (1991). Interleukin-6 enhances motility of breast carcinoma cells. In: Goldberg ID (ed). Cell Motility Factors. Birkhauser Verlag: Basel–Boston–Berlin, pp 178–193.
Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: 2940–2947.
Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB . (1989). Interleukin-6 immunoreactivity in human tumors. Am J Pathol 135: 427–433.
Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB . (1989). Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170: 1649–1669.
Tamm I, Cardinale I, Murphy JS . (1991a). Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci USA 88: 4414–4418.
Tamm I, Cardinale I, Sehgal PB . (1991b). Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells. Cytokine 3: 212–223.
Tamm I, Cardinale I, Kikuchi T, Krueger JG . (1994a). E-cadherin distribution in interleukin-6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 4338–4342.
Tamm I, Kikuchi T, Cardinale I, Krueger JG . (1994b). Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 3329–3333.
Tamm I, Kikuchi T, Cardinale I, Murphy JS, Krueger JG . (1998). Cytokines in breast cancer cell dyshesion. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89–106.
Walter M, Liang S, Ghosh S, Hornsby PJ, Li R . (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745–2755.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Sehgal's work has been funded by the NIH.
Rights and permissions
About this article
Cite this article
Sehgal, P. Interleukin-6 induces increased motility, cell–cell and cell–substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells. Oncogene 29, 2599–2600 (2010). https://doi.org/10.1038/onc.2010.4
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.4
This article is cited by
-
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients
Breast Cancer Research (2012)
-
Response to Sehgal
Oncogene (2010)